View Financial HealthSynergy CHC 배당 및 자사주 매입배당 기준 점검 0/6Synergy CHC 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-101.6%자사주 매입 수익률총 주주 수익률-101.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 18Synergy CHC Corp. Announces Notice Of Non-Compliance With Minimum Bid Price Requirement From NasdaqSynergy CHC Corp. received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, based on the closing bid price of the Company's common stock for the last 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice has no immediate effect on the listing of the Company's common stock on Nasdaq. Pursuant to the Nasdaq Listing Rules, the Company has been provided an initial compliance period of 180 calendar days to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days prior to November 11, 2026. If the Company does not regain compliance by November 11, 2026, the Company may be eligible for an additional 180 calendar day compliance period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split if necessary. If the Company does not regain compliance within the compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company's common stock will be subject to delisting. The Company intends to monitor the closing bid price of the Company's common stock and consider its available options to resolve the noncompliance with the Minimum Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or maintain compliance with other applicable Nasdaq listing requirements.공시 • Apr 21Synergy CHC Corp., Annual General Meeting, Jun 29, 2026Synergy CHC Corp., Annual General Meeting, Jun 29, 2026.공시 • Apr 02Synergy CHC Corp. announced delayed annual 10-K filingOn 04/01/2026, Synergy CHC Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.New Risk • Mar 31New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Negative equity (-US$8.3m). High level of non-cash earnings (82% accrual ratio). Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (7.5% net profit margin). Market cap is less than US$100m (US$13.6m market cap).공시 • Mar 18Synergy CHC Corp. to Report Q4, 2025 Results on Mar 31, 2026Synergy CHC Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Mar 31, 2026새로운 내러티브 • Mar 05Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins AheadCatalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?공시 • Feb 27Synergy CHC Corp. announced that it expects to receive $31.3 million in fundingSynergy CHC Corp. announced a private placement of Common Shares of the company to raise gross proceeds of $31,300,000 on February 27, 2026.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to US$1.30, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 19x in the Personal Products industry in the US. Total returns to shareholders of 337% over the past three years.새로운 내러티브 • Feb 17Brain Health And Clean Energy Trends Will Support Long Term Undervaluation ThesisCatalysts About Synergy CHC Synergy CHC develops and sells FOCUSfactor branded brain health supplements and functional beverages across retail, convenience and international channels. What are the underlying business or industry changes driving this perspective?새로운 내러티브 • Feb 03Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings PowerCatalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional energy and brain health beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?분석 기사 • Jan 28Investors Aren't Buying Synergy CHC Corp.'s (NASDAQ:SNYR) EarningsWhen close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...공시 • Dec 17Synergy CHC Corp. Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico &Latin AmericaSynergy CHC Corp. announced that Pedro Colmenares has been appointed Director of Sales &Marketing for Mexico &Latin America. In this role, Mr. Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region. Mr. Colmenares joins the Company at a pivotal time as it advances its international growth strategy. As announced in May 2025, Synergy established a wholly owned subsidiary in Mexico and has begun its initial market entry through shipments of its supplement products to Costco Mexico this week. As Director of Sales and Marketing for Mexico and Latin America, he will play a central role in executing this strategy and driving growth across both the Companys supplement and functional beverage portfolios, building a scalable commercial foundation to support long-term growth. Mr. Colmenares is a senior commercial executive with over 18 years of experience across the pharmaceutical, nutraceutical, OTC, and consumer health sectors. He has successfully led market entry and expansion initiatives throughout Mexico and Latin America, consistently transforming underdeveloped markets into high-performing, sustainable businesses. His background includes leadership roles at Procter &Gamble and Victus/Megalabs, where he built scaled regional sales, marketing, and distribution platforms through strategic partnerships and omnichannel execution. Throughout his career, Mr. Colmenares has launched and developed operations in multiple countries across Latin America, driving accelerated growth through disciplined go-to-market strategies, localized brand development, and strong retailer and supplier relationships. His experience spans both multinational and regional organizations, providing a deep understanding of the operational and cultural dynamics required to scale consumer health brands in the region.Valuation Update With 7 Day Price Move • Dec 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$1.84, the stock trades at a trailing P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in the US. Total loss to shareholders of 65% over the past year.공시 • Nov 27Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $5.69 million.Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $5.69 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering분석 기사 • Nov 20Should You Think About Buying Synergy CHC Corp. (NASDAQ:SNYR) Now?Synergy CHC Corp. ( NASDAQ:SNYR ), is not the largest company out there, but it saw a decent share price growth of 18...Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: US$0.012 (vs US$0.10 in 3Q 2024)Third quarter 2025 results: EPS: US$0.012 (down from US$0.10 in 3Q 2024). Revenue: US$8.01m (up 12% from 3Q 2024). Net income: US$125.3k (down 84% from 3Q 2024). Profit margin: 1.6% (down from 11% in 3Q 2024). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Personal Products industry in the US.공시 • Oct 31Synergy CHC Corp. to Report Q3, 2025 Results on Nov 13, 2025Synergy CHC Corp. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$2.69, the stock trades at a trailing P/E ratio of 9.3x. Average forward P/E is 15x in the Personal Products industry in the US.Board Change • Sep 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Nitin Kaushal was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 23Synergy CHC Corp. Announces Management AppointmentsSynergy CHC Corp. announced two key leadership changes: Scott Woodburn has been appointed to Head of Strategic Partnerships to drive the Company’s expansion in functional beverages, and Teresa Thompson has been appointed to Synergy’s Board of Directors (the “Board”), effective immediately. In connection with Woodburn’s new role, he has resigned from the Board. Thompson will also serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, filling the positions previously held by Woodburn.Scott Woodburn, who has served on Synergy’s Board since October 2024, brings over 30 years of executive leadership across the global beverage and consumer goods industries. A former Vice President of National and Global Accounts at Coca-Cola, he has led international brand growth, executed large-scale sales strategies, and built enduring partnerships with major retail and QSR chains. He also leads a beverage-focused consulting firm, serves as an advisor to investment bank Silverwood Partners, and most recently held the role of SVP of Sales at Fuling USA. With a proven track record scaling Fortune 500 brands, Woodburn is set to accelerate Synergy’s beverage innovation and market expansion in the rapidly growing $100B+ global energy and wellness drinks market. Synergy has appointed Teresa Thompson to its Board of Directors, filling the vacancy created by Woodburn’s transition. Thompson is a seasoned retail executive with nearly four decades of experience at Costco Wholesale, including 29 years as a Pharmacy OTC Buyer. In that role, she oversaw the vitamins and supplements categories for Costco’s U.S. warehouses, managing vendor relationships, optimizing product assortments, and implementing strategic initiatives that enhanced the customer experience.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$2.56, the stock trades at a trailing P/E ratio of 8.8x. Average forward P/E is 15x in the Personal Products industry in the US. Total returns to shareholders of 7.6% over the past year.New Risk • Aug 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 48% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Negative equity (-US$12m). High level of non-cash earnings (84% accrual ratio). Shareholders have been substantially diluted in the past year (48% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (US$23.4m market cap).분석 기사 • Aug 27Synergy CHC's (NASDAQ:SNYR) Problems Go Beyond Poor ProfitSynergy CHC Corp.'s ( NASDAQ:SNYR ) lackluster earnings announcement last week disappointed investors. We think that...공시 • Aug 26Synergy CHC Corp. has completed a Follow-on Equity Offering in the amount of $4.375 million.Synergy CHC Corp. has completed a Follow-on Equity Offering in the amount of $4.375 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,750,000 Price\Range: $2.5 Discount Per Security: $0.175Valuation Update With 7 Day Price Move • Aug 21Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to US$2.90, the stock trades at a trailing P/E ratio of 8.5x. Average forward P/E is 16x in the Personal Products industry in the US.공시 • Aug 16Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $4.999999 million.Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $4.999999 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,275,510 Price\Range: $3.92Reported Earnings • Aug 15Second quarter 2025 earnings released: EPS: US$0.17 (vs US$0.087 in 2Q 2024)Second quarter 2025 results: EPS: US$0.17 (up from US$0.087 in 2Q 2024). Revenue: US$8.13m (up 1.4% from 2Q 2024). Net income: US$1.47m (up 125% from 2Q 2024). Profit margin: 18% (up from 8.2% in 2Q 2024). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Personal Products industry in the US.Recent Insider Transactions • Aug 03CEO & Chairman recently bought US$80k worth of stockOn the 30th of July, Jack Ross bought around 28k shares on-market at roughly US$2.85 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Jack has been a buyer over the last 12 months, purchasing a net total of US$2.9m worth in shares.공시 • Aug 01Synergy CHC Corp. to Report Q2, 2025 Results on Aug 14, 2025Synergy CHC Corp. announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025Valuation Update With 7 Day Price Move • Jul 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$3.61, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 203% over the past year.Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improves as stock rises 33%After last week's 33% share price gain to US$3.24, the stock trades at a trailing P/E ratio of 12.1x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 4,850% over the past three years.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 27%After last week's 27% share price gain to US$2.65, the stock trades at a trailing P/E ratio of 9.9x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 3,949% over the past three years.Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$2.07, the stock trades at a trailing P/E ratio of 7.7x. Average forward P/E is 23x in the Personal Products industry in the US. Total returns to shareholders of 3,063% over the past three years.New Risk • May 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-US$16m). High level of non-cash earnings (83% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (7.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (US$17.7m market cap).Reported Earnings • May 15First quarter 2025 earnings released: EPS: US$0.10 (vs US$0.077 in 1Q 2024)First quarter 2025 results: EPS: US$0.10 (up from US$0.077 in 1Q 2024). Revenue: US$8.17m (down 13% from 1Q 2024). Net income: US$876.3k (up 51% from 1Q 2024). Profit margin: 11% (up from 6.2% in 1Q 2024). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Personal Products industry in the US.Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$1.77, the stock trades at a trailing P/E ratio of 7.1x. Average forward P/E is 19x in the Personal Products industry in the US. Total returns to shareholders of 2,875% over the past three years.공시 • May 02Synergy CHC Corp. to Report Q1, 2025 Results on May 15, 2025Synergy CHC Corp. announced that they will report Q1, 2025 results Pre-Market on May 15, 2025공시 • Apr 19Synergy CHC Corp., Annual General Meeting, Jun 18, 2025Synergy CHC Corp., Annual General Meeting, Jun 18, 2025.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 40%After last week's 40% share price gain to US$2.50, the stock trades at a trailing P/E ratio of 10.1x. Average forward P/E is 16x in the Personal Products industry in the US. Total returns to shareholders of 6,903% over the past three years.New Risk • Apr 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Negative equity (-US$17m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (US$19.7m market cap).Reported Earnings • Mar 31Full year 2024 earnings released: EPS: US$0.28 (vs US$0.84 in FY 2023)Full year 2024 results: EPS: US$0.28 (down from US$0.84 in FY 2023). Revenue: US$34.8m (down 19% from FY 2023). Net income: US$2.12m (down 67% from FY 2023). Profit margin: 6.1% (down from 15% in FY 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the US.Valuation Update With 7 Day Price Move • Mar 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$3.02, the stock trades at a trailing P/E ratio of 5.7x. Average forward P/E is 17x in the Personal Products industry in the US. Total returns to shareholders of 12,589% over the past three years.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorates as stock falls 28%After last week's 28% share price decline to US$3.02, the stock trades at a trailing P/E ratio of 5.7x. Average forward P/E is 21x in the Personal Products industry in the US. Total returns to shareholders of 22,971% over the past three years.Valuation Update With 7 Day Price Move • Jan 16Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$4.15, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 26x in the Personal Products industry in the US. Total returns to shareholders of 31,604% over the past three years.공시 • Nov 27Synergy CHC Corp. to Report Q3, 2024 Results on Dec 06, 2024Synergy CHC Corp. announced that they will report Q3, 2024 results Pre-Market on Dec 06, 2024공시 • Oct 25Synergy CHC Corp. Common Stock Deleted from OTC EquitySynergy CHC Corp. Common Stock has been deleted from OTC Equity effective October 23, 2024, due to Market Center Change Listed on NASDAQ.공시 • Oct 23Synergy CHC Corp. has completed an IPO in the amount of $10.35 million.Synergy CHC Corp. has completed an IPO in the amount of $10.35 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,150,000 Price\Range: $9 Discount Per Security: $0.63공시 • Jun 28Synergy CHC Corp. has filed an IPO in the amount of $23 million.Synergy CHC Corp. has filed an IPO in the amount of $23 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: New Market Listing공시 • Jul 18Synergy CHC Files Form 15Synergy CHC Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common Stock, par value $0.00001 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 SNYR 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: SNYR 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Synergy CHC 배당 수익률 vs 시장SNYR의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (SNYR)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Personal Products)3.4%분석가 예측 (SNYR) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 SNYR 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 SNYR 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 SNYR 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: SNYR 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 17:37종가2026/05/21 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Synergy CHC Corp.는 2명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Edward WooAscendiant Capital Markets LLCSean McGowanRoth Capital Partners
공시 • May 18Synergy CHC Corp. Announces Notice Of Non-Compliance With Minimum Bid Price Requirement From NasdaqSynergy CHC Corp. received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, based on the closing bid price of the Company's common stock for the last 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive business days. The Notice has no immediate effect on the listing of the Company's common stock on Nasdaq. Pursuant to the Nasdaq Listing Rules, the Company has been provided an initial compliance period of 180 calendar days to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days prior to November 11, 2026. If the Company does not regain compliance by November 11, 2026, the Company may be eligible for an additional 180 calendar day compliance period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split if necessary. If the Company does not regain compliance within the compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company's common stock will be subject to delisting. The Company intends to monitor the closing bid price of the Company's common stock and consider its available options to resolve the noncompliance with the Minimum Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or maintain compliance with other applicable Nasdaq listing requirements.
공시 • Apr 21Synergy CHC Corp., Annual General Meeting, Jun 29, 2026Synergy CHC Corp., Annual General Meeting, Jun 29, 2026.
공시 • Apr 02Synergy CHC Corp. announced delayed annual 10-K filingOn 04/01/2026, Synergy CHC Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
New Risk • Mar 31New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Negative equity (-US$8.3m). High level of non-cash earnings (82% accrual ratio). Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (7.5% net profit margin). Market cap is less than US$100m (US$13.6m market cap).
공시 • Mar 18Synergy CHC Corp. to Report Q4, 2025 Results on Mar 31, 2026Synergy CHC Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Mar 31, 2026
새로운 내러티브 • Mar 05Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins AheadCatalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?
공시 • Feb 27Synergy CHC Corp. announced that it expects to receive $31.3 million in fundingSynergy CHC Corp. announced a private placement of Common Shares of the company to raise gross proceeds of $31,300,000 on February 27, 2026.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to US$1.30, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 19x in the Personal Products industry in the US. Total returns to shareholders of 337% over the past three years.
새로운 내러티브 • Feb 17Brain Health And Clean Energy Trends Will Support Long Term Undervaluation ThesisCatalysts About Synergy CHC Synergy CHC develops and sells FOCUSfactor branded brain health supplements and functional beverages across retail, convenience and international channels. What are the underlying business or industry changes driving this perspective?
새로운 내러티브 • Feb 03Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings PowerCatalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional energy and brain health beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?
분석 기사 • Jan 28Investors Aren't Buying Synergy CHC Corp.'s (NASDAQ:SNYR) EarningsWhen close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...
공시 • Dec 17Synergy CHC Corp. Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico &Latin AmericaSynergy CHC Corp. announced that Pedro Colmenares has been appointed Director of Sales &Marketing for Mexico &Latin America. In this role, Mr. Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region. Mr. Colmenares joins the Company at a pivotal time as it advances its international growth strategy. As announced in May 2025, Synergy established a wholly owned subsidiary in Mexico and has begun its initial market entry through shipments of its supplement products to Costco Mexico this week. As Director of Sales and Marketing for Mexico and Latin America, he will play a central role in executing this strategy and driving growth across both the Companys supplement and functional beverage portfolios, building a scalable commercial foundation to support long-term growth. Mr. Colmenares is a senior commercial executive with over 18 years of experience across the pharmaceutical, nutraceutical, OTC, and consumer health sectors. He has successfully led market entry and expansion initiatives throughout Mexico and Latin America, consistently transforming underdeveloped markets into high-performing, sustainable businesses. His background includes leadership roles at Procter &Gamble and Victus/Megalabs, where he built scaled regional sales, marketing, and distribution platforms through strategic partnerships and omnichannel execution. Throughout his career, Mr. Colmenares has launched and developed operations in multiple countries across Latin America, driving accelerated growth through disciplined go-to-market strategies, localized brand development, and strong retailer and supplier relationships. His experience spans both multinational and regional organizations, providing a deep understanding of the operational and cultural dynamics required to scale consumer health brands in the region.
Valuation Update With 7 Day Price Move • Dec 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$1.84, the stock trades at a trailing P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in the US. Total loss to shareholders of 65% over the past year.
공시 • Nov 27Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $5.69 million.Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $5.69 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
분석 기사 • Nov 20Should You Think About Buying Synergy CHC Corp. (NASDAQ:SNYR) Now?Synergy CHC Corp. ( NASDAQ:SNYR ), is not the largest company out there, but it saw a decent share price growth of 18...
Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: US$0.012 (vs US$0.10 in 3Q 2024)Third quarter 2025 results: EPS: US$0.012 (down from US$0.10 in 3Q 2024). Revenue: US$8.01m (up 12% from 3Q 2024). Net income: US$125.3k (down 84% from 3Q 2024). Profit margin: 1.6% (down from 11% in 3Q 2024). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Personal Products industry in the US.
공시 • Oct 31Synergy CHC Corp. to Report Q3, 2025 Results on Nov 13, 2025Synergy CHC Corp. announced that they will report Q3, 2025 results Pre-Market on Nov 13, 2025
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$2.69, the stock trades at a trailing P/E ratio of 9.3x. Average forward P/E is 15x in the Personal Products industry in the US.
Board Change • Sep 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Nitin Kaushal was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 23Synergy CHC Corp. Announces Management AppointmentsSynergy CHC Corp. announced two key leadership changes: Scott Woodburn has been appointed to Head of Strategic Partnerships to drive the Company’s expansion in functional beverages, and Teresa Thompson has been appointed to Synergy’s Board of Directors (the “Board”), effective immediately. In connection with Woodburn’s new role, he has resigned from the Board. Thompson will also serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, filling the positions previously held by Woodburn.Scott Woodburn, who has served on Synergy’s Board since October 2024, brings over 30 years of executive leadership across the global beverage and consumer goods industries. A former Vice President of National and Global Accounts at Coca-Cola, he has led international brand growth, executed large-scale sales strategies, and built enduring partnerships with major retail and QSR chains. He also leads a beverage-focused consulting firm, serves as an advisor to investment bank Silverwood Partners, and most recently held the role of SVP of Sales at Fuling USA. With a proven track record scaling Fortune 500 brands, Woodburn is set to accelerate Synergy’s beverage innovation and market expansion in the rapidly growing $100B+ global energy and wellness drinks market. Synergy has appointed Teresa Thompson to its Board of Directors, filling the vacancy created by Woodburn’s transition. Thompson is a seasoned retail executive with nearly four decades of experience at Costco Wholesale, including 29 years as a Pharmacy OTC Buyer. In that role, she oversaw the vitamins and supplements categories for Costco’s U.S. warehouses, managing vendor relationships, optimizing product assortments, and implementing strategic initiatives that enhanced the customer experience.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$2.56, the stock trades at a trailing P/E ratio of 8.8x. Average forward P/E is 15x in the Personal Products industry in the US. Total returns to shareholders of 7.6% over the past year.
New Risk • Aug 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 48% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Negative equity (-US$12m). High level of non-cash earnings (84% accrual ratio). Shareholders have been substantially diluted in the past year (48% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (US$23.4m market cap).
분석 기사 • Aug 27Synergy CHC's (NASDAQ:SNYR) Problems Go Beyond Poor ProfitSynergy CHC Corp.'s ( NASDAQ:SNYR ) lackluster earnings announcement last week disappointed investors. We think that...
공시 • Aug 26Synergy CHC Corp. has completed a Follow-on Equity Offering in the amount of $4.375 million.Synergy CHC Corp. has completed a Follow-on Equity Offering in the amount of $4.375 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,750,000 Price\Range: $2.5 Discount Per Security: $0.175
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to US$2.90, the stock trades at a trailing P/E ratio of 8.5x. Average forward P/E is 16x in the Personal Products industry in the US.
공시 • Aug 16Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $4.999999 million.Synergy CHC Corp. has filed a Follow-on Equity Offering in the amount of $4.999999 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,275,510 Price\Range: $3.92
Reported Earnings • Aug 15Second quarter 2025 earnings released: EPS: US$0.17 (vs US$0.087 in 2Q 2024)Second quarter 2025 results: EPS: US$0.17 (up from US$0.087 in 2Q 2024). Revenue: US$8.13m (up 1.4% from 2Q 2024). Net income: US$1.47m (up 125% from 2Q 2024). Profit margin: 18% (up from 8.2% in 2Q 2024). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Personal Products industry in the US.
Recent Insider Transactions • Aug 03CEO & Chairman recently bought US$80k worth of stockOn the 30th of July, Jack Ross bought around 28k shares on-market at roughly US$2.85 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Jack has been a buyer over the last 12 months, purchasing a net total of US$2.9m worth in shares.
공시 • Aug 01Synergy CHC Corp. to Report Q2, 2025 Results on Aug 14, 2025Synergy CHC Corp. announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025
Valuation Update With 7 Day Price Move • Jul 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$3.61, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 203% over the past year.
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improves as stock rises 33%After last week's 33% share price gain to US$3.24, the stock trades at a trailing P/E ratio of 12.1x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 4,850% over the past three years.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 27%After last week's 27% share price gain to US$2.65, the stock trades at a trailing P/E ratio of 9.9x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 3,949% over the past three years.
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$2.07, the stock trades at a trailing P/E ratio of 7.7x. Average forward P/E is 23x in the Personal Products industry in the US. Total returns to shareholders of 3,063% over the past three years.
New Risk • May 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-US$16m). High level of non-cash earnings (83% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (7.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (US$17.7m market cap).
Reported Earnings • May 15First quarter 2025 earnings released: EPS: US$0.10 (vs US$0.077 in 1Q 2024)First quarter 2025 results: EPS: US$0.10 (up from US$0.077 in 1Q 2024). Revenue: US$8.17m (down 13% from 1Q 2024). Net income: US$876.3k (up 51% from 1Q 2024). Profit margin: 11% (up from 6.2% in 1Q 2024). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Personal Products industry in the US.
Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$1.77, the stock trades at a trailing P/E ratio of 7.1x. Average forward P/E is 19x in the Personal Products industry in the US. Total returns to shareholders of 2,875% over the past three years.
공시 • May 02Synergy CHC Corp. to Report Q1, 2025 Results on May 15, 2025Synergy CHC Corp. announced that they will report Q1, 2025 results Pre-Market on May 15, 2025
공시 • Apr 19Synergy CHC Corp., Annual General Meeting, Jun 18, 2025Synergy CHC Corp., Annual General Meeting, Jun 18, 2025.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 40%After last week's 40% share price gain to US$2.50, the stock trades at a trailing P/E ratio of 10.1x. Average forward P/E is 16x in the Personal Products industry in the US. Total returns to shareholders of 6,903% over the past three years.
New Risk • Apr 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Negative equity (-US$17m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (US$19.7m market cap).
Reported Earnings • Mar 31Full year 2024 earnings released: EPS: US$0.28 (vs US$0.84 in FY 2023)Full year 2024 results: EPS: US$0.28 (down from US$0.84 in FY 2023). Revenue: US$34.8m (down 19% from FY 2023). Net income: US$2.12m (down 67% from FY 2023). Profit margin: 6.1% (down from 15% in FY 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the US.
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$3.02, the stock trades at a trailing P/E ratio of 5.7x. Average forward P/E is 17x in the Personal Products industry in the US. Total returns to shareholders of 12,589% over the past three years.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorates as stock falls 28%After last week's 28% share price decline to US$3.02, the stock trades at a trailing P/E ratio of 5.7x. Average forward P/E is 21x in the Personal Products industry in the US. Total returns to shareholders of 22,971% over the past three years.
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$4.15, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 26x in the Personal Products industry in the US. Total returns to shareholders of 31,604% over the past three years.
공시 • Nov 27Synergy CHC Corp. to Report Q3, 2024 Results on Dec 06, 2024Synergy CHC Corp. announced that they will report Q3, 2024 results Pre-Market on Dec 06, 2024
공시 • Oct 25Synergy CHC Corp. Common Stock Deleted from OTC EquitySynergy CHC Corp. Common Stock has been deleted from OTC Equity effective October 23, 2024, due to Market Center Change Listed on NASDAQ.
공시 • Oct 23Synergy CHC Corp. has completed an IPO in the amount of $10.35 million.Synergy CHC Corp. has completed an IPO in the amount of $10.35 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,150,000 Price\Range: $9 Discount Per Security: $0.63
공시 • Jun 28Synergy CHC Corp. has filed an IPO in the amount of $23 million.Synergy CHC Corp. has filed an IPO in the amount of $23 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: New Market Listing
공시 • Jul 18Synergy CHC Files Form 15Synergy CHC Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common Stock, par value $0.00001 per share.
